Please login or register to print this page.

Clinical Articles, News & Views

New heart failure treatments on horizon

Dissatisfaction with limited chronic heart failure (CHF) therapies, and the fast-expanding patient population, are encouraging the development of new drug options and superior treatments, according to a new report by GlobalData.1

Demand is growing for new treatment options that can present improved safety and efficacy and unique new molecules that can restore or regenerate impaired cardiac muscle cells, according to the report.

Various pipeline molecules are expected to enter the market within the next few years to improve options for CHF patients, it says, reporting that there are 41 molecules under development in the CHF therapeutics pipeline, of which 78% are First-in-Class (FIC) and 25% are in Phase III.

Several molecules are currently being clinically tested for safety and efficacy in improving cardiac function, and many upcoming drugs include novel mechanisms  for the treatment and management of CHF.  Stem cell therapy may also be capable of improving the CHF treatment pattern, the report says, with the potential to restore cardiac muscle function by regenerating and strengthening heart muscle cells.

GlobalData analysis finds that the global CHF therapeutics market grew at a Compound Annual Growth Rate (CAGR) of 4% from $3,171.3m in 2006 to $3,849.9m in 2011. The report suggests that market will grow at a CAGR of 3.1% during the forecast period, to reach $4,918.4m by 2019.

References

1 Chronic Heart Failure (CHF) Therapeutics – Pipeline Assessment and Market Forecasts to 2019.  GlobalData 2012.  Available from http://www.globaldata.com/reportstore/Report.aspx?ID=Chronic-Heart-Failure-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2018&companyID=jpr)

Published on: April 18, 2012

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.